230 related articles for article (PubMed ID: 24285261)
1. New strategies in treating male lower urinary tract symptoms.
Füllhase C; Soler R; Gratzke C
Curr Opin Urol; 2014 Jan; 24(1):29-35. PubMed ID: 24285261
[TBL] [Abstract][Full Text] [Related]
2. Current medical treatment of lower urinary tract symptoms/BPH: do we have a standard?
Silva J; Silva CM; Cruz F
Curr Opin Urol; 2014 Jan; 24(1):21-8. PubMed ID: 24231531
[TBL] [Abstract][Full Text] [Related]
3. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction.
Oelke M; Bachmann A; Descazeaud A; Emberton M; Gravas S; Michel MC; N'dow J; Nordling J; de la Rosette JJ;
Eur Urol; 2013 Jul; 64(1):118-40. PubMed ID: 23541338
[TBL] [Abstract][Full Text] [Related]
4. Future direction in pharmacotherapy for non-neurogenic male lower urinary tract symptoms.
Soler R; Andersson KE; Chancellor MB; Chapple CR; de Groat WC; Drake MJ; Gratzke C; Lee R; Cruz F
Eur Urol; 2013 Oct; 64(4):610-21. PubMed ID: 23711541
[TBL] [Abstract][Full Text] [Related]
5. Latest treatment for lower urinary tract dysfunction: therapeutic agents and mechanism of action.
Yamaguchi O
Int J Urol; 2013 Jan; 20(1):28-39. PubMed ID: 23190275
[TBL] [Abstract][Full Text] [Related]
6. Medical treatment of lower urinary tract symptoms/benign prostatic hyperplasia: anything new in 2015.
Schauer I; Madersbacher S
Curr Opin Urol; 2015 Jan; 25(1):6-11. PubMed ID: 25393269
[TBL] [Abstract][Full Text] [Related]
7. Potential Future Pharmacological Treatment of Bladder Dysfunction.
Andersson KE
Basic Clin Pharmacol Toxicol; 2016 Oct; 119 Suppl 3():75-85. PubMed ID: 26990140
[TBL] [Abstract][Full Text] [Related]
8. Medical management of lower urinary tract symptoms in men with benign prostatic enlargement.
Marberger M
Adv Ther; 2013 Apr; 30(4):309-19. PubMed ID: 23584673
[TBL] [Abstract][Full Text] [Related]
9. Systematic review of combination drug therapy for non-neurogenic male lower urinary tract symptoms.
Füllhase C; Chapple C; Cornu JN; De Nunzio C; Gratzke C; Kaplan SA; Marberger M; Montorsi F; Novara G; Oelke M; Porst H; Roehrborn C; Stief C; McVary KT
Eur Urol; 2013 Aug; 64(2):228-43. PubMed ID: 23375241
[TBL] [Abstract][Full Text] [Related]
10. The use of pharmacotherapy for male patients with urgency and stress incontinence.
Andersson KE
Curr Opin Urol; 2014 Nov; 24(6):571-7. PubMed ID: 25144147
[TBL] [Abstract][Full Text] [Related]
11. Comparative Effectiveness of Newer Medications for Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis.
Dahm P; Brasure M; MacDonald R; Olson CM; Nelson VA; Fink HA; Rwabasonga B; Risk MC; Wilt TJ
Eur Urol; 2017 Apr; 71(4):570-581. PubMed ID: 27717522
[TBL] [Abstract][Full Text] [Related]
12. Lower Urinary Tract Symptoms: What's New in Medical Treatment?
Peyronnet B; Brucker BM; Michel MC
Eur Urol Focus; 2018 Jan; 4(1):17-24. PubMed ID: 29665997
[TBL] [Abstract][Full Text] [Related]
13. Management of lower urinary tract symptoms related to benign prostatic hyperplasia in real-life practice in france: a comprehensive population study.
Lukacs B; Cornu JN; Aout M; Tessier N; Hodée C; Haab F; Cussenot O; Merlière Y; Moysan V; Vicaut E
Eur Urol; 2013 Sep; 64(3):493-501. PubMed ID: 23465519
[TBL] [Abstract][Full Text] [Related]
14. [Initial assessment, follow-up and treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: guidelines of the LUTS committee of the French Urological Association].
Descazeaud A; Robert G; Delongchamps NB; Cornu JN; Saussine C; Haillot O; Devonec M; Fourmarier M; Ballereau C; Lukacs B; Dumonceau O; Azzouzi AR; Faix A; Desgrandchamps F; de la Taille A;
Prog Urol; 2012 Dec; 22(16):977-88. PubMed ID: 23178093
[TBL] [Abstract][Full Text] [Related]
15. Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia.
Gacci M; Eardley I; Giuliano F; Hatzichristou D; Kaplan SA; Maggi M; McVary KT; Mirone V; Porst H; Roehrborn CG
Eur Urol; 2011 Oct; 60(4):809-25. PubMed ID: 21726934
[TBL] [Abstract][Full Text] [Related]
16. The use of mono- and combination drug therapy in men and women with lower urinary tract symptoms (LUTS) in the UK: a retrospective observational study.
Ali M; Landeira M; Covernton PJO; Choudhury N; Jaggi A; Fatoye F; van Maanen R
BMC Urol; 2021 Sep; 21(1):119. PubMed ID: 34474675
[TBL] [Abstract][Full Text] [Related]
17. Silodosin in the management of lower urinary tract symptoms as a result of benign prostatic hyperplasia: who are the best candidates.
Capitanio U; Salonia A; Briganti A; Montorsi F
Int J Clin Pract; 2013 Jun; 67(6):544-51. PubMed ID: 23409749
[TBL] [Abstract][Full Text] [Related]
18. Solifenacin plus tamsulosin combination treatment in men with lower urinary tract symptoms and bladder outlet obstruction: a randomized controlled trial.
Kaplan SA; He W; Koltun WD; Cummings J; Schneider T; Fakhoury A
Eur Urol; 2013 Jan; 63(1):158-65. PubMed ID: 22831853
[TBL] [Abstract][Full Text] [Related]
19. Management of Benign Prostatic Hyperplasia in Older Adults.
Woodard TJ; Manigault KR; McBurrows NN; Wray TL; Woodard LM
Consult Pharm; 2016; 31(8):412-24. PubMed ID: 27535076
[TBL] [Abstract][Full Text] [Related]
20. [New treatment strategies for male lower urinary tract symptoms].
Arenas da Silva LF; Schönthaler M; Cruz F; Gratzke C; Zumbe J; Stenzl A; Amend B; Sievert KD
Urologe A; 2012 Dec; 51(12):1697-702. PubMed ID: 23139025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]